Phenotypic expressions of childhood wheezing and asthma: Implications for therapy

Bradley E. Chipps; Leonard B. Bacharier; Julia M. Harder

doi:10.1016/j.jpeds.2011.01.057

Phenotypic expressions of childhood wheezing and asthma: Implications for therapy

Bradley E. Chipps, Leonard B. Bacharier, Julia M. Harder

Division of Allergy & Pulmonary Medicine

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Original language	English
Pages (from-to)	878-884.e1
Journal	Journal of Pediatrics
Volume	158
Issue number	6
DOIs	https://doi.org/10.1016/j.jpeds.2011.01.057
State	Published - Jun 2011

Access to Document

10.1016/j.jpeds.2011.01.057

Cite this

@article{00407aef9b2c4fd8a6d117f46e278601,

title = "Phenotypic expressions of childhood wheezing and asthma: Implications for therapy",

author = "Chipps, {Bradley E.} and Bacharier, {Leonard B.} and Harder, {Julia M.}",

note = "Funding Information: B.C. is a consultant for Alcon, Sanofi-Aventis, Genentech, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sepracor, Merck-Schering, ISTA, Quintiles, and Dey; he received grant support from Alcon, Sanofi-Aventis, Genentech, AstraZeneca, GlaxoSmithKline, Novartis, Sepracor, and Merck-Schering ; he is on the speaker{\textquoteright}s bureau for Alcon, Sanofi-Aventis, Genentech, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Meda, Novartis, Pfizer, Sepracor, Merck-Schering, and ISTA; and served as an expert witness in mold litigation. L.B. received honoraria from AstraZeneca, Genentech, GlaxoSmithKline, Merck, and Aerocrine; he served on the advisory board for AstraZeneca, Merck, and GlaxoSmithKline; and received research support from the National Institutes of Health/National Heart, Lung, and Blood Institute . ",

year = "2011",

month = jun,

doi = "10.1016/j.jpeds.2011.01.057",

language = "English",

volume = "158",

pages = "878--884.e1",

journal = "Journal of Pediatrics",

issn = "0022-3476",

number = "6",

}

TY - JOUR

T1 - Phenotypic expressions of childhood wheezing and asthma

T2 - Implications for therapy

AU - Chipps, Bradley E.

AU - Bacharier, Leonard B.

AU - Harder, Julia M.

N1 - Funding Information: B.C. is a consultant for Alcon, Sanofi-Aventis, Genentech, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sepracor, Merck-Schering, ISTA, Quintiles, and Dey; he received grant support from Alcon, Sanofi-Aventis, Genentech, AstraZeneca, GlaxoSmithKline, Novartis, Sepracor, and Merck-Schering ; he is on the speaker’s bureau for Alcon, Sanofi-Aventis, Genentech, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Meda, Novartis, Pfizer, Sepracor, Merck-Schering, and ISTA; and served as an expert witness in mold litigation. L.B. received honoraria from AstraZeneca, Genentech, GlaxoSmithKline, Merck, and Aerocrine; he served on the advisory board for AstraZeneca, Merck, and GlaxoSmithKline; and received research support from the National Institutes of Health/National Heart, Lung, and Blood Institute .

PY - 2011/6

Y1 - 2011/6

UR - http://www.scopus.com/inward/record.url?scp=79956042283&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2011.01.057

DO - 10.1016/j.jpeds.2011.01.057

M3 - Article

C2 - 21429508

AN - SCOPUS:79956042283

SN - 0022-3476

VL - 158

SP - 878-884.e1

JO - Journal of Pediatrics

JF - Journal of Pediatrics

IS - 6

ER -

Phenotypic expressions of childhood wheezing and asthma: Implications for therapy

Access to Document

Other files and links

Cite this